| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/ECI.12.99 |
| P698 | PubMed publication ID | 23445198 |
| P2093 | author name string | Antoine Malek | |
| P2860 | cites work | Management of Rhesus Alloimmunization in Pregnancy | Q22242754 |
| Dynamics of immunoglobulins at the feto-maternal interface | Q22305976 | ||
| A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus | Q24337337 | ||
| The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans | Q28208533 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat | Q29027111 | ||
| Effect of in utero and early-life conditions on adult health and disease | Q29615797 | ||
| Isolation and characterization of the Fc receptor from the fetal yolk sac of the rat | Q30442290 | ||
| Histochemistry for placenta research: theory and application | Q33299447 | ||
| Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development | Q33380175 | ||
| Imaging of placental transport mechanisms: a review | Q33419552 | ||
| Transplacental immunization of the human fetus to tetanus by immunization of the mother | Q33822318 | ||
| Hypothesis: thalidomide embryopathy-proposed mechanism of action | Q33831075 | ||
| Mesenchymal stem cell therapy: Two steps forward, one step back | Q33898653 | ||
| RhD haemolytic disease of the fetus and the newborn | Q33901403 | ||
| Regulation of antibody responses via antibodies, complement, and Fc receptors | Q33932750 | ||
| Multiple roles for the major histocompatibility complex class I- related receptor FcRn | Q33932754 | ||
| Immunology of placentation in eutherian mammals | Q33997922 | ||
| Mechanism of anti-D-mediated immune suppression--a paradox awaiting resolution? | Q34207523 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology | Q34507918 | ||
| The who, how and where of antigen presentation to B cells | Q34601866 | ||
| Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy | Q34908712 | ||
| Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy | Q34992282 | ||
| Efficient mother-to-child transfer of antiretroviral immunity in the context of preclinical monoclonal antibody-based immunotherapy | Q35101489 | ||
| B cells as effectors | Q35145806 | ||
| Placental transport of immunoglobulin G. | Q35172881 | ||
| A comparison of placental development and endocrine functions between the human and mouse model | Q35625079 | ||
| Mechanisms regulating toxicant disposition to the embryo during early pregnancy: an interspecies comparison | Q36016074 | ||
| Role of transporters in placental transfer of drugs | Q36175517 | ||
| Intestinal transport of antibodies in the newborn rat | Q36195279 | ||
| Monoclonal anti-D antibodies to prevent alloimmunization: lessons from clinical trials | Q36437660 | ||
| Animal models of human placentation--a review | Q36695431 | ||
| An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta | Q36814851 | ||
| The human placenta--an alternative for studying foetal exposure. | Q36877122 | ||
| Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers | Q36903911 | ||
| FcRn: the neonatal Fc receptor comes of age. | Q36912134 | ||
| Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells | Q36987698 | ||
| Therapeutic applications of mesenchymal stromal cells. | Q37006910 | ||
| ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy | Q37073260 | ||
| FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus | Q37178738 | ||
| Clinical practice. Asthma in pregnancy | Q37464563 | ||
| Strategies to extend plasma half-lives of recombinant antibodies | Q37505008 | ||
| An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies | Q37559465 | ||
| Asthma and pregnancy: emerging evidence of epigenetic interactions in utero | Q37571371 | ||
| Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding | Q37626638 | ||
| Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn. | Q37653175 | ||
| Thyroid function and pregnancy: before, during and beyond. | Q37815179 | ||
| Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease. | Q37845884 | ||
| Prevention and treatment of allergic asthma in pregnancy: from conventional drugs to new therapeutical approaches | Q37845886 | ||
| Nanoparticulate drug delivery in pregnancy: placental passage and fetal exposure | Q37845889 | ||
| Acquired and inherited thrombophilia disorders in pregnancy | Q37875948 | ||
| Thyroid physiology and autoimmunity in pregnancy and after delivery | Q37927084 | ||
| Review: The evolving placenta: different developmental paths to a hemochorial relationship | Q37953607 | ||
| Current international initiatives in antiphospholipid antibody testing | Q38009237 | ||
| Anaphylaxis during pregnancy | Q38032645 | ||
| Thalidomide embryopathy | Q39678672 | ||
| Prenatal stress enhances susceptibility of murine adult offspring toward airway inflammation | Q40263882 | ||
| Isolation of multipotent cells from human term placenta. | Q40457999 | ||
| Maternal and fetal thyroid function | Q40705970 | ||
| The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology | Q41497461 | ||
| Human placental Fc receptors and the transmission of antibodies from mother to fetus | Q41720397 | ||
| Comparative placental structure | Q41739258 | ||
| Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells | Q42444844 | ||
| Uptake and intracellular routing of peroxidase-conjugated immunoglobulin-G by the perfused human placenta | Q42485840 | ||
| Rabbit peroxidase-antiperoxidase complex (PAP) as a model for the uptake of immunoglobulin G by the human placenta | Q42527601 | ||
| Structural and functional aspects of porcine placental microvasculature | Q43519543 | ||
| Localization of three subtypes of Fcγ receptors in human placenta by immunohistochemical analysis | Q43869694 | ||
| The diagnosis and management of anaphylaxis: an updated practice parameter | Q45309391 | ||
| Transfer of specific IgG and IgG subclasses to herpes simplex virus across the blood-brain barrier and placenta in preterm and term newborns | Q45871114 | ||
| Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization | Q46345200 | ||
| Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999. | Q46346428 | ||
| The transmission of immunity from mother to young and the catabolism of immunoglobulins | Q46606572 | ||
| A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network | Q47376419 | ||
| Options and limitations in studies of successive pregnancy outcomes: an overview. | Q53566168 | ||
| Experimental studies on the prevention of Rh haemolytic disease. | Q55717766 | ||
| Antiphospholipid syndrome | Q55891386 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Drug development for use during pregnancy: impact of the placenta | Q58392274 | ||
| Energy charge monitoring via magnetic resonance spectroscopy 31P in the perfused human placenta: effects of cadmium, dinitrophenol and lodoacetate | Q58392350 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 235-249 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Expert Review of Clinical Immunology | Q15733763 |
| P1476 | title | Role of IgG antibodies in association with placental function and immunologic diseases in human pregnancy | |
| P478 | volume | 9 |
| Q30909526 | Advanced MR imaging of the placenta: Exploring the in utero placenta-brain connection |
| Q38661263 | Challenges in vaccinating infants born to mothers taking immunoglobulin biologicals during pregnancy |
| Q58699144 | Hormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy |
| Q64118852 | Maternal Immune Response During Pregnancy and Vertical Transmission in Human Toxoplasmosis |
| Q38835801 | Passive immunisation, an old idea revisited: Basic principles and application to modern animal production systems. |
| Q43583667 | Placental transfer of Fc-containing biopharmaceuticals across species, an industry survey analysis |
| Q57462861 | Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents |
| Q92480104 | Reduced membrane attack complex formation in umbilical cord blood during Eculizumab treatment of the mother: a case report |
| Q47120638 | Retrospective comparative study of the factors affecting birthweights in frozen-thawed embryo transfer, compared to fresh embryo transfer. |
| Q55069144 | Seroreactivity to Anisakis spp. in the perinatal period. |
Search more.